As of Apr 2, 2025, the Penumbra stock's PE ratio is 770.42. This takes into account the latest EPS of $0.36 and stock price of $277.35. The PE ratio has grown by 114% from its last 4 quarters average of 360.4.
The PE ratio of Penumbra has averaged 475.24 over the last ten years. The current P/E ratio of 770.42 is 62% higher than the historical average. Looking back at the last ten years, PEN's PE ratio peaked in the Dec 2021 quarter at 2,052.29, when the price was $287.32 and the EPS was $0.14. The lowest point was in the Mar 2024 quarter, when it reached 92.22 with a price of $223.18 and an EPS of $2.42.
Maximum annual increase: 521.51% in 2024
Maximum annual decrease: -81.63% in 2019
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 659.67 | 521.51% | $237.48 | $0.36 |
2023 | 106.14 | N/A | $251.54 | $2.37 |
2022 | N/A | N/A | $222.46 | -$0.05 |
2021 | 2,052.29 | N/A | $287.32 | $0.14 |
2020 | N/A | N/A | $175 | -$0.44 |
2019 | 118.18 | -81.63% | $164.27 | $1.39 |
2018 | 643.16 | -4.31% | $122.2 | $0.19 |
2017 | 672.14 | 416.24% | $94.1 | $0.14 |
2016 | 130.2 | -78.22% | $63.8 | $0.49 |
2015 | 597.89 | N/A | $53.81 | $0.09 |
2014 | N/A | N/A | N/A | -$0.18 |
2013 | N/A | N/A | N/A | $0.21 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 659.67 | 205.54% | $237.48 | $0.36 |
Sep 2024 | 215.9 | -54.41% | $194.31 | $0.9 |
Jun 2024 | 473.61 | 413.57% | $179.97 | $0.38 |
Mar 2024 | 92.22 | -13.11% | $223.18 | $2.42 |
Dec 2023 | 106.14 | -53.49% | $251.54 | $2.37 |
Sep 2023 | 228.22 | -49.59% | $241.91 | $1.06 |
Jun 2023 | 452.71 | -72.38% | $344.06 | $0.76 |
Mar 2023 | 1,639.35 | N/A | $278.69 | $0.17 |
Dec 2022 | N/A | N/A | $222.46 | -$0.05 |
Sep 2022 | N/A | N/A | $189.6 | -$0.84 |
Jun 2022 | N/A | N/A | $124.52 | -$0.54 |
Mar 2022 | N/A | N/A | $222.13 | -$0.19 |
Dec 2021 | 2,052.29 | 600.78% | $287.32 | $0.14 |
Sep 2021 | 292.86 | -54.05% | $266.5 | $0.91 |
Jun 2021 | 637.35 | N/A | $274.06 | $0.43 |
The current PE ratio of PEN is higher than its 3 and 5-year averages.
Stock name | PE ratio | Market cap |
---|---|---|
PEN Penumbra Inc | 762.72 | $10.58B |
NVRO Nevro Corp | N/A | $221.4M |
OFIX Orthofix Medical Inc | N/A | $617.73M |
NURO NeuroMetrix Inc | N/A | $9.19M |
PEN stock has a price to earnings ratio of 770.42 as of Apr 2, 2025.
As an average over the last 3 years, PEN stock has a PE ratio of 483.48.
As an average over the last 5 years, PEN stock has a PE ratio of 620.53.
Over the last ten years, the quarterly PE ratio reached its highest level at 2,052.29 in the Dec 2021 quarter.
PEN's price to earnings ratio is currently 62% above its 10-year historical average.
PEN's PE ratio is high because the stock price is relatively expensive compared to the earnings generated by the company.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Apr 2, 2025), Penumbra's share price is $277.35. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.36. Therefore, Penumbra's PE ratio for today is 770.42. PE RATIO(770.42) = STOCK PRICE($277.35) / TTM EPS($0.36)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.